These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
307 related articles for article (PubMed ID: 25001480)
1. Silencing RhoA inhibits migration and invasion through Wnt/β-catenin pathway and growth through cell cycle regulation in human tongue cancer. Yan G; Zou R; Chen Z; Fan B; Wang Z; Wang Y; Yin X; Zhang D; Tong L; Yang F; Jiang W; Fu W; Zheng J; Bergo MO; Dalin M; Zheng J; Chen S; Zhou J Acta Biochim Biophys Sin (Shanghai); 2014 Aug; 46(8):682-90. PubMed ID: 25001480 [TBL] [Abstract][Full Text] [Related]
2. Upregulation of the long non-coding RNA AFAP1-AS1 affects the proliferation, invasion and survival of tongue squamous cell carcinoma via the Wnt/β-catenin signaling pathway. Wang ZY; Hu M; Dai MH; Xiong J; Zhang S; Wu HJ; Zhang SS; Gong ZJ Mol Cancer; 2018 Jan; 17(1):3. PubMed ID: 29310682 [TBL] [Abstract][Full Text] [Related]
3. R-spondin 2-LGR4 system regulates growth, migration and invasion, epithelial-mesenchymal transition and stem-like properties of tongue squamous cell carcinoma via Wnt/β-catenin signaling. Zhang L; Song Y; Ling Z; Li Y; Ren X; Yang J; Wang Z; Xia J; Zhang W; Cheng B EBioMedicine; 2019 Jun; 44():275-288. PubMed ID: 31097406 [TBL] [Abstract][Full Text] [Related]
4. Galectin-3 accelerates the progression of oral tongue squamous cell carcinoma via a Wnt/β-catenin-dependent pathway. Wang LP; Chen SW; Zhuang SM; Li H; Song M Pathol Oncol Res; 2013 Jul; 19(3):461-74. PubMed ID: 23519607 [TBL] [Abstract][Full Text] [Related]
5. Beclin1 inhibits proliferation, migration and invasion in tongue squamous cell carcinoma cell lines. Weng J; Wang C; Wang Y; Tang H; Liang J; Liu X; Huang H; Hou J Oral Oncol; 2014 Oct; 50(10):983-90. PubMed ID: 25096824 [TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA LINC00961 inhibited cell proliferation and invasion through regulating the Wnt/β-catenin signaling pathway in tongue squamous cell carcinoma. Zhang L; Shao L; Hu Y J Cell Biochem; 2019 Aug; 120(8):12429-12435. PubMed ID: 30854692 [TBL] [Abstract][Full Text] [Related]
7. TRAF4 enhances oral squamous cell carcinoma cell growth, invasion and migration by Wnt-β-catenin signaling pathway. Yang J; Wei D; Wang W; Shen B; Xu S; Cao Y Int J Clin Exp Pathol; 2015; 8(9):11837-46. PubMed ID: 26617938 [TBL] [Abstract][Full Text] [Related]
8. Galectin-3 gene silencing inhibits migration and invasion of human tongue cancer cells in vitro via downregulating β-catenin. Zhang D; Chen ZG; Liu SH; Dong ZQ; Dalin M; Bao SS; Hu YW; Wei FC Acta Pharmacol Sin; 2013 Jan; 34(1):176-84. PubMed ID: 23103626 [TBL] [Abstract][Full Text] [Related]
9. An essential role for N-cadherin and beta-catenin for progression in tongue squamous cell carcinoma and their effect on invasion and metastasis of Tca8113 tongue cancer cells. Li S; Jiao J; Lu Z; Zhang M Oncol Rep; 2009 May; 21(5):1223-33. PubMed ID: 19360298 [TBL] [Abstract][Full Text] [Related]
10. [hsa_circ_0000231 affects the progression of tongue squamous cell carcinoma by activating Wnt/β-catenin signaling pathway]. Chen QW; Wang DQ; Ding BX; Tang MM; Li XG; Zhou JY; Xu K; Fang ZR; Han L; Wu H Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 Oct; 57(10):1230-1239. PubMed ID: 36319130 [No Abstract] [Full Text] [Related]
11. [Effects of RhoA gene silencing by RNA interference on invasion of tongue carcinoma]. Chen Z; Tang YP; Tong L; Wang Y; Zhou Y; Wang Q; Han J; He Z; Liao Y; Fan B; Zou RH; Zhang J; Sun X; Yan G Hua Xi Kou Qiang Yi Xue Za Zhi; 2016 Apr; 34(2):183-8. PubMed ID: 27337930 [TBL] [Abstract][Full Text] [Related]
12. MALAT1 induces tongue cancer cells' EMT and inhibits apoptosis through Wnt/β-catenin signaling pathway. Liang J; Liang L; Ouyang K; Li Z; Yi X J Oral Pathol Med; 2017 Feb; 46(2):98-105. PubMed ID: 27353727 [TBL] [Abstract][Full Text] [Related]
13. miR-373-3p Targets DKK1 to Promote EMT-Induced Metastasis via the Wnt/ Weng J; Zhang H; Wang C; Liang J; Chen G; Li W; Tang H; Hou J Biomed Res Int; 2017; 2017():6010926. PubMed ID: 28337453 [TBL] [Abstract][Full Text] [Related]
14. Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo. Ramachandran I; Thavathiru E; Ramalingam S; Natarajan G; Mills WK; Benbrook DM; Zuna R; Lightfoot S; Reis A; Anant S; Queimado L Oncogene; 2012 May; 31(22):2725-37. PubMed ID: 22002305 [TBL] [Abstract][Full Text] [Related]
15. Obovatol inhibits the growth and aggressiveness of tongue squamous cell carcinoma through regulation of the EGF‑mediated JAK‑STAT signaling pathway. Duan M; Du X; Ren G; Zhang Y; Zheng Y; Sun S; Zhang J Mol Med Rep; 2018 Aug; 18(2):1651-1659. PubMed ID: 29845251 [TBL] [Abstract][Full Text] [Related]
16. Overexpression of HMGA2 promotes tongue cancer metastasis through EMT pathway. Zhao XP; Zhang H; Jiao JY; Tang DX; Wu YL; Pan CB J Transl Med; 2016 Jan; 14():26. PubMed ID: 26818837 [TBL] [Abstract][Full Text] [Related]
17. FGF1-FGFR1 axis promotes tongue squamous cell carcinoma (TSCC) metastasis through epithelial-mesenchymal transition (EMT). Jiao J; Zhao X; Liang Y; Tang D; Pan C Biochem Biophys Res Commun; 2015 Oct; 466(3):327-32. PubMed ID: 26362179 [TBL] [Abstract][Full Text] [Related]
18. Wnt5b promotes the cell motility essential for metastasis of oral squamous cell carcinoma through active Cdc42 and RhoA. Takeshita A; Iwai S; Morita Y; Niki-Yonekawa A; Hamada M; Yura Y Int J Oncol; 2014 Jan; 44(1):59-68. PubMed ID: 24220306 [TBL] [Abstract][Full Text] [Related]
19. SOX8 regulates cancer stem-like properties and cisplatin-induced EMT in tongue squamous cell carcinoma by acting on the Wnt/β-catenin pathway. Xie SL; Fan S; Zhang SY; Chen WX; Li QX; Pan GK; Zhang HQ; Wang WW; Weng B; Zhang Z; Li JS; Lin ZY Int J Cancer; 2018 Mar; 142(6):1252-1265. PubMed ID: 29071717 [TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA NKILA inhibits migration and invasion of tongue squamous cell carcinoma cells via suppressing epithelial-mesenchymal transition. Huang W; Cui X; Chen J; Feng Y; Song E; Li J; Liu Y Oncotarget; 2016 Sep; 7(38):62520-62532. PubMed ID: 27613832 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]